High Oct4 expression: implications in the pathogenesis of neuroblastic tumours View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-01-03

AUTHORS

Ezequiel Monferrer, Rebeca Burgos-Panadero, Maite Blanquer-Maceiras, Adela Cañete, Samuel Navarro, Rosa Noguera

ABSTRACT

BACKGROUND: Neuroblastic tumours (NBTs) are paediatric solid tumours derived from embryonic neural crest cells which harbour their own cancer stem cells (CSC). There is evidence indicating that CSC may be responsible for tumour progression, chemotherapy resistance and recurrence in NBTs. Oct4 is a transcription factor which plays a key role in mammal embryonic development and stem cell fate regulation. The aim of the study is to elucidate the clinical significance of Oct4 in NBTs. METHODS: We studied Oct4 expression in 563 primary NBTs using digital image quantification. Chi-square test was applied to analyse the correlation between histopathology and the Oct4+ cell percentage. Survival analysis was carried out with Kaplan-Meier curves and log-rank test. Additionally, a multivariate Cox regression analysis with the stepwise backwards (Wald) method was undertaken to calculate the impact of Oct4 expression level on survival. RESULTS: We found that tumours with a high proportion of cells expressing Oct4 correlated statistically with undifferentiated and poorly differentiated neuroblastoma / nodular ganglioneuroblastoma, and that Oct4 expression was not present in ganglioneuroma (p < 0.05). Statistical analysis also indicated a relationship between high Oct4 expression levels, high-risk patients according to the International Neuroblastoma Risk Group pre-treatment classification parameters, larger blood vessels and low survival rates. CONCLUSIONS: These results suggest that the Oct4 gene may regulate NBT pathogenic differentiation pathways, and should thus be considered as a target for knockdown when developing novel therapies for high-risk NBT patients. More... »

PAGES

1

References to SciGraph publications

  • 2003-03. Neuroblastoma: biological insights into a clinical enigma in NATURE REVIEWS CANCER
  • 2013-11-11. Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma in PEDIATRIC RESEARCH
  • 2012-06-20. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring in DIAGNOSTIC PATHOLOGY
  • 2011-06-28. Challenging issues in pediatric oncology in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2011-06-22. OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast Cancer in LABORATORY ANIMAL RESEARCH
  • 2002-12. Stem cell pluripotency and transcription factor Oct4 in CELL RESEARCH
  • 2009-04-28. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee in BRITISH JOURNAL OF CANCER
  • 2001-12-11. Human embryonic genes re-expressed in cancer cells in ONCOGENE
  • 2016-11-10. Knockdown of OCT4 may sensitize NSCLC cells to cisplatin in CLINICAL AND TRANSLATIONAL ONCOLOGY
  • 2012-01-30. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation in ONCOGENE
  • 2015-03-11. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2011-03-15. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells in CELL RESEARCH
  • 2011-07-02. Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma in JOURNAL OF NEURO-ONCOLOGY
  • 2016-07-14. Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort in BRITISH JOURNAL OF CANCER
  • 2017-04-13. Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling in SCIENTIFIC REPORTS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12885-018-5219-3

    DOI

    http://dx.doi.org/10.1186/s12885-018-5219-3

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1111097025

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30606139


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ganglioneuroblastoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ganglioneuroma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Regulation, Neoplastic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kaplan-Meier Estimate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplastic Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neural Crest", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neuroblastoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Octamer Transcription Factor-3", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proportional Hazards Models", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5338.d", 
              "name": [
                "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Monferrer", 
            "givenName": "Ezequiel", 
            "id": "sg:person.015256724557.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015256724557.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5338.d", 
              "name": [
                "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Burgos-Panadero", 
            "givenName": "Rebeca", 
            "id": "sg:person.016054305157.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016054305157.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CIBERONC, Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain", 
                "CIBERONC, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Blanquer-Maceiras", 
            "givenName": "Maite", 
            "id": "sg:person.0751173613.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751173613.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pediatric Oncology Unit, University and Polytechnic Hospital La Fe, Valencia, Spain", 
              "id": "http://www.grid.ac/institutes/grid.84393.35", 
              "name": [
                "Pediatric Oncology Unit, University and Polytechnic Hospital La Fe, Valencia, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ca\u00f1ete", 
            "givenName": "Adela", 
            "id": "sg:person.01223656116.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223656116.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CIBERONC, Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain", 
                "CIBERONC, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Navarro", 
            "givenName": "Samuel", 
            "id": "sg:person.0654426367.57", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654426367.57"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CIBERONC, Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ib\u00e1\u00f1ez, 15, 46010 Valencia, Spain", 
                "CIBERONC, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Noguera", 
            "givenName": "Rosa", 
            "id": "sg:person.01012303663.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012303663.29"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.5625/lar.2011.27.2.147", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043688918", 
              "https://doi.org/10.5625/lar.2011.27.2.147"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1746-1596-7-42", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013484875", 
              "https://doi.org/10.1186/1746-1596-7-42"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2011.656", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024757614", 
              "https://doi.org/10.1038/onc.2011.656"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cr.7290134", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025225165", 
              "https://doi.org/10.1038/sj.cr.7290134"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep46312", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084812236", 
              "https://doi.org/10.1038/srep46312"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-011-0647-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006040703", 
              "https://doi.org/10.1007/s11060-011-0647-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cr.2011.38", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017528148", 
              "https://doi.org/10.1038/cr.2011.38"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1205088", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027779487", 
              "https://doi.org/10.1038/sj.onc.1205088"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12094-016-1569-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043312651", 
              "https://doi.org/10.1007/s12094-016-1569-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.2016.210", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036915213", 
              "https://doi.org/10.1038/bjc.2016.210"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6605014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053161948", 
              "https://doi.org/10.1038/sj.bjc.6605014"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2011.95", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022584996", 
              "https://doi.org/10.1038/nrclinonc.2011.95"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc1014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008818340", 
              "https://doi.org/10.1038/nrc1014"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/pr.2013.217", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037381848", 
              "https://doi.org/10.1038/pr.2013.217"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13045-015-0119-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026038001", 
              "https://doi.org/10.1186/s13045-015-0119-3"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-01-03", 
        "datePublishedReg": "2019-01-03", 
        "description": "BACKGROUND: Neuroblastic tumours (NBTs) are paediatric solid tumours derived from embryonic neural crest cells which harbour their own cancer stem cells (CSC). There is evidence indicating that CSC may be responsible for tumour progression, chemotherapy resistance and recurrence in NBTs. Oct4 is a transcription factor which plays a key role in mammal embryonic development and stem cell fate regulation. The aim of the study is to elucidate the clinical significance of Oct4 in NBTs.\nMETHODS: We studied Oct4 expression in 563 primary NBTs using digital image quantification. Chi-square test was applied to analyse the correlation between histopathology and the Oct4+ cell percentage. Survival analysis was carried out with Kaplan-Meier curves and log-rank test. Additionally, a multivariate Cox regression analysis with the stepwise backwards (Wald) method was undertaken to calculate the impact of Oct4 expression level on survival.\nRESULTS: We found that tumours with a high proportion of cells expressing Oct4 correlated statistically with undifferentiated and poorly differentiated neuroblastoma / nodular ganglioneuroblastoma, and that Oct4 expression was not present in ganglioneuroma (p\u2009<\u20090.05). Statistical analysis also indicated a relationship between high Oct4 expression levels, high-risk patients according to the International Neuroblastoma Risk Group pre-treatment classification parameters, larger blood vessels and low survival rates.\nCONCLUSIONS: These results suggest that the Oct4 gene may regulate NBT pathogenic differentiation pathways, and should thus be considered as a target for knockdown when developing novel therapies for high-risk NBT patients.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12885-018-5219-3", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1024632", 
            "issn": [
              "1471-2407"
            ], 
            "name": "BMC Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "19"
          }
        ], 
        "keywords": [
          "cancer stem cells", 
          "neuroblastic tumors", 
          "OCT4 expression levels", 
          "own cancer stem cells", 
          "multivariate Cox regression analysis", 
          "high-risk patients", 
          "Cox regression analysis", 
          "Kaplan-Meier curves", 
          "log-rank test", 
          "pediatric solid tumors", 
          "expression levels", 
          "primary neuroblastic tumors", 
          "chi-square test", 
          "lower survival rate", 
          "nodular ganglioneuroblastoma", 
          "embryonic neural crest cells", 
          "novel therapies", 
          "clinical significance", 
          "large blood vessels", 
          "cell percentage", 
          "Oct4 expression", 
          "solid tumors", 
          "chemotherapy resistance", 
          "survival rate", 
          "survival analysis", 
          "tumor progression", 
          "neural crest cells", 
          "blood vessels", 
          "tumors", 
          "patients", 
          "regression analysis", 
          "digital image quantification", 
          "crest cells", 
          "stem cells", 
          "differentiation pathway", 
          "higher proportion", 
          "cells", 
          "ganglioneuroblastoma", 
          "ganglioneuroma", 
          "recurrence", 
          "statistical analysis", 
          "histopathology", 
          "therapy", 
          "pathogenesis", 
          "transcription factors", 
          "expression", 
          "progression", 
          "key role", 
          "survival", 
          "levels", 
          "embryonic development", 
          "knockdown", 
          "image quantification", 
          "vessels", 
          "test", 
          "aim", 
          "Oct4 gene", 
          "pathway", 
          "proportion", 
          "percentage", 
          "evidence", 
          "cell fate regulation", 
          "target", 
          "factors", 
          "significance", 
          "study", 
          "analysis", 
          "role", 
          "genes", 
          "regulation", 
          "rate", 
          "correlation", 
          "fate regulation", 
          "resistance", 
          "development", 
          "relationship", 
          "quantification", 
          "stepwise", 
          "impact", 
          "curves", 
          "implications", 
          "results", 
          "analyse", 
          "classification parameters", 
          "method", 
          "parameters", 
          "mammal embryonic development", 
          "neuroblastoma / nodular ganglioneuroblastoma", 
          "high Oct4 expression levels", 
          "International Neuroblastoma Risk Group pre-treatment classification parameters", 
          "Neuroblastoma Risk Group pre-treatment classification parameters", 
          "Risk Group pre-treatment classification parameters", 
          "Group pre-treatment classification parameters", 
          "pre-treatment classification parameters", 
          "pathogenic differentiation pathways"
        ], 
        "name": "High Oct4 expression: implications in the pathogenesis of neuroblastic tumours", 
        "pagination": "1", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1111097025"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12885-018-5219-3"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30606139"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12885-018-5219-3", 
          "https://app.dimensions.ai/details/publication/pub.1111097025"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-11-01T18:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_820.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12885-018-5219-3"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-5219-3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-5219-3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-5219-3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-5219-3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    314 TRIPLES      22 PREDICATES      150 URIs      127 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12885-018-5219-3 schema:about N104b7b989e9540779ee9a1c93d921d20
    2 N212cdf032edd4d5297554a8239a21845
    3 N27c89d56a2194422a86469b75ca46fb6
    4 N315614a41ac14dacadc89efb5f4aaca8
    5 N455e9e1170c94043b0258b129375c479
    6 N50a5038fa84048e1823f7b0aa837dd96
    7 N5d8728f5d9984519b4201350adcf55a2
    8 N5e91bed34dbf415384d8fb23f109379c
    9 N6e67fccf777f4a2b9c2594cff8e16a05
    10 Nb7ab5f5d087641bd9f03fe42e4213c6d
    11 Nbad2c726f93045f0b3a9fc89f010023c
    12 Nbe613c4572b3467c8956b3c8954b1444
    13 Ncbe2bdfb3aff49d092c90c7885c24bac
    14 Nd88e745862a3469daef82045d200ca7e
    15 anzsrc-for:11
    16 anzsrc-for:1112
    17 schema:author N31c07c2ea0564e928af04c7af55304fa
    18 schema:citation sg:pub.10.1007/s11060-011-0647-9
    19 sg:pub.10.1007/s12094-016-1569-y
    20 sg:pub.10.1038/bjc.2016.210
    21 sg:pub.10.1038/cr.2011.38
    22 sg:pub.10.1038/nrc1014
    23 sg:pub.10.1038/nrclinonc.2011.95
    24 sg:pub.10.1038/onc.2011.656
    25 sg:pub.10.1038/pr.2013.217
    26 sg:pub.10.1038/sj.bjc.6605014
    27 sg:pub.10.1038/sj.cr.7290134
    28 sg:pub.10.1038/sj.onc.1205088
    29 sg:pub.10.1038/srep46312
    30 sg:pub.10.1186/1746-1596-7-42
    31 sg:pub.10.1186/s13045-015-0119-3
    32 sg:pub.10.5625/lar.2011.27.2.147
    33 schema:datePublished 2019-01-03
    34 schema:datePublishedReg 2019-01-03
    35 schema:description BACKGROUND: Neuroblastic tumours (NBTs) are paediatric solid tumours derived from embryonic neural crest cells which harbour their own cancer stem cells (CSC). There is evidence indicating that CSC may be responsible for tumour progression, chemotherapy resistance and recurrence in NBTs. Oct4 is a transcription factor which plays a key role in mammal embryonic development and stem cell fate regulation. The aim of the study is to elucidate the clinical significance of Oct4 in NBTs. METHODS: We studied Oct4 expression in 563 primary NBTs using digital image quantification. Chi-square test was applied to analyse the correlation between histopathology and the Oct4<sup>+</sup> cell percentage. Survival analysis was carried out with Kaplan-Meier curves and log-rank test. Additionally, a multivariate Cox regression analysis with the stepwise backwards (Wald) method was undertaken to calculate the impact of Oct4 expression level on survival. RESULTS: We found that tumours with a high proportion of cells expressing Oct4 correlated statistically with undifferentiated and poorly differentiated neuroblastoma / nodular ganglioneuroblastoma, and that Oct4 expression was not present in ganglioneuroma (p &lt; 0.05). Statistical analysis also indicated a relationship between high Oct4 expression levels, high-risk patients according to the International Neuroblastoma Risk Group pre-treatment classification parameters, larger blood vessels and low survival rates. CONCLUSIONS: These results suggest that the Oct4 gene may regulate NBT pathogenic differentiation pathways, and should thus be considered as a target for knockdown when developing novel therapies for high-risk NBT patients.
    36 schema:genre article
    37 schema:inLanguage en
    38 schema:isAccessibleForFree true
    39 schema:isPartOf Ndae7b590a7594905bc05c75da3253c16
    40 Ndd0791b3c4c7454492d9862133f9b8be
    41 sg:journal.1024632
    42 schema:keywords Cox regression analysis
    43 Group pre-treatment classification parameters
    44 International Neuroblastoma Risk Group pre-treatment classification parameters
    45 Kaplan-Meier curves
    46 Neuroblastoma Risk Group pre-treatment classification parameters
    47 OCT4 expression levels
    48 Oct4 expression
    49 Oct4 gene
    50 Risk Group pre-treatment classification parameters
    51 aim
    52 analyse
    53 analysis
    54 blood vessels
    55 cancer stem cells
    56 cell fate regulation
    57 cell percentage
    58 cells
    59 chemotherapy resistance
    60 chi-square test
    61 classification parameters
    62 clinical significance
    63 correlation
    64 crest cells
    65 curves
    66 development
    67 differentiation pathway
    68 digital image quantification
    69 embryonic development
    70 embryonic neural crest cells
    71 evidence
    72 expression
    73 expression levels
    74 factors
    75 fate regulation
    76 ganglioneuroblastoma
    77 ganglioneuroma
    78 genes
    79 high Oct4 expression levels
    80 high-risk patients
    81 higher proportion
    82 histopathology
    83 image quantification
    84 impact
    85 implications
    86 key role
    87 knockdown
    88 large blood vessels
    89 levels
    90 log-rank test
    91 lower survival rate
    92 mammal embryonic development
    93 method
    94 multivariate Cox regression analysis
    95 neural crest cells
    96 neuroblastic tumors
    97 neuroblastoma / nodular ganglioneuroblastoma
    98 nodular ganglioneuroblastoma
    99 novel therapies
    100 own cancer stem cells
    101 parameters
    102 pathogenesis
    103 pathogenic differentiation pathways
    104 pathway
    105 patients
    106 pediatric solid tumors
    107 percentage
    108 pre-treatment classification parameters
    109 primary neuroblastic tumors
    110 progression
    111 proportion
    112 quantification
    113 rate
    114 recurrence
    115 regression analysis
    116 regulation
    117 relationship
    118 resistance
    119 results
    120 role
    121 significance
    122 solid tumors
    123 statistical analysis
    124 stem cells
    125 stepwise
    126 study
    127 survival
    128 survival analysis
    129 survival rate
    130 target
    131 test
    132 therapy
    133 transcription factors
    134 tumor progression
    135 tumors
    136 vessels
    137 schema:name High Oct4 expression: implications in the pathogenesis of neuroblastic tumours
    138 schema:pagination 1
    139 schema:productId N12e072a7888a4daea98ea616abb23d66
    140 N52162fcd399444dd9a875fd862816f6d
    141 N619c450cf25549858d09074ea8dee1b1
    142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111097025
    143 https://doi.org/10.1186/s12885-018-5219-3
    144 schema:sdDatePublished 2021-11-01T18:36
    145 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    146 schema:sdPublisher N77eb6e9793b643408b13a0b041caec4f
    147 schema:url https://doi.org/10.1186/s12885-018-5219-3
    148 sgo:license sg:explorer/license/
    149 sgo:sdDataset articles
    150 rdf:type schema:ScholarlyArticle
    151 N104b7b989e9540779ee9a1c93d921d20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Ganglioneuroblastoma
    153 rdf:type schema:DefinedTerm
    154 N12e072a7888a4daea98ea616abb23d66 schema:name dimensions_id
    155 schema:value pub.1111097025
    156 rdf:type schema:PropertyValue
    157 N212cdf032edd4d5297554a8239a21845 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Neural Crest
    159 rdf:type schema:DefinedTerm
    160 N27c89d56a2194422a86469b75ca46fb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Kaplan-Meier Estimate
    162 rdf:type schema:DefinedTerm
    163 N303f6b9fd22c43a9b75e36f2d44189a0 rdf:first sg:person.01012303663.29
    164 rdf:rest rdf:nil
    165 N315614a41ac14dacadc89efb5f4aaca8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Proportional Hazards Models
    167 rdf:type schema:DefinedTerm
    168 N31c07c2ea0564e928af04c7af55304fa rdf:first sg:person.015256724557.42
    169 rdf:rest Nd5e489ab014f4519ab4eb00f711eff3c
    170 N455e9e1170c94043b0258b129375c479 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Neoplastic Stem Cells
    172 rdf:type schema:DefinedTerm
    173 N50a5038fa84048e1823f7b0aa837dd96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Female
    175 rdf:type schema:DefinedTerm
    176 N52162fcd399444dd9a875fd862816f6d schema:name doi
    177 schema:value 10.1186/s12885-018-5219-3
    178 rdf:type schema:PropertyValue
    179 N5d8728f5d9984519b4201350adcf55a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Octamer Transcription Factor-3
    181 rdf:type schema:DefinedTerm
    182 N5e91bed34dbf415384d8fb23f109379c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Neuroblastoma
    184 rdf:type schema:DefinedTerm
    185 N619c450cf25549858d09074ea8dee1b1 schema:name pubmed_id
    186 schema:value 30606139
    187 rdf:type schema:PropertyValue
    188 N6e67fccf777f4a2b9c2594cff8e16a05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Infant
    190 rdf:type schema:DefinedTerm
    191 N77eb6e9793b643408b13a0b041caec4f schema:name Springer Nature - SN SciGraph project
    192 rdf:type schema:Organization
    193 Nae26a2c01e9840488e0bc31e753e157c rdf:first sg:person.0751173613.52
    194 rdf:rest Nb2526e786a3043e7abd9c0619dba96b7
    195 Nb2526e786a3043e7abd9c0619dba96b7 rdf:first sg:person.01223656116.14
    196 rdf:rest Ndf8b71e5f0904cb399d0f4a064c47ba6
    197 Nb7ab5f5d087641bd9f03fe42e4213c6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Ganglioneuroma
    199 rdf:type schema:DefinedTerm
    200 Nbad2c726f93045f0b3a9fc89f010023c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Humans
    202 rdf:type schema:DefinedTerm
    203 Nbe613c4572b3467c8956b3c8954b1444 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Male
    205 rdf:type schema:DefinedTerm
    206 Ncbe2bdfb3aff49d092c90c7885c24bac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Gene Expression Regulation, Neoplastic
    208 rdf:type schema:DefinedTerm
    209 Nd5e489ab014f4519ab4eb00f711eff3c rdf:first sg:person.016054305157.92
    210 rdf:rest Nae26a2c01e9840488e0bc31e753e157c
    211 Nd88e745862a3469daef82045d200ca7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Biomarkers, Tumor
    213 rdf:type schema:DefinedTerm
    214 Ndae7b590a7594905bc05c75da3253c16 schema:volumeNumber 19
    215 rdf:type schema:PublicationVolume
    216 Ndd0791b3c4c7454492d9862133f9b8be schema:issueNumber 1
    217 rdf:type schema:PublicationIssue
    218 Ndf8b71e5f0904cb399d0f4a064c47ba6 rdf:first sg:person.0654426367.57
    219 rdf:rest N303f6b9fd22c43a9b75e36f2d44189a0
    220 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    221 schema:name Medical and Health Sciences
    222 rdf:type schema:DefinedTerm
    223 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    224 schema:name Oncology and Carcinogenesis
    225 rdf:type schema:DefinedTerm
    226 sg:journal.1024632 schema:issn 1471-2407
    227 schema:name BMC Cancer
    228 schema:publisher Springer Nature
    229 rdf:type schema:Periodical
    230 sg:person.01012303663.29 schema:affiliation grid-institutes:None
    231 schema:familyName Noguera
    232 schema:givenName Rosa
    233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012303663.29
    234 rdf:type schema:Person
    235 sg:person.01223656116.14 schema:affiliation grid-institutes:grid.84393.35
    236 schema:familyName Cañete
    237 schema:givenName Adela
    238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223656116.14
    239 rdf:type schema:Person
    240 sg:person.015256724557.42 schema:affiliation grid-institutes:grid.5338.d
    241 schema:familyName Monferrer
    242 schema:givenName Ezequiel
    243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015256724557.42
    244 rdf:type schema:Person
    245 sg:person.016054305157.92 schema:affiliation grid-institutes:grid.5338.d
    246 schema:familyName Burgos-Panadero
    247 schema:givenName Rebeca
    248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016054305157.92
    249 rdf:type schema:Person
    250 sg:person.0654426367.57 schema:affiliation grid-institutes:None
    251 schema:familyName Navarro
    252 schema:givenName Samuel
    253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654426367.57
    254 rdf:type schema:Person
    255 sg:person.0751173613.52 schema:affiliation grid-institutes:None
    256 schema:familyName Blanquer-Maceiras
    257 schema:givenName Maite
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751173613.52
    259 rdf:type schema:Person
    260 sg:pub.10.1007/s11060-011-0647-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006040703
    261 https://doi.org/10.1007/s11060-011-0647-9
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1007/s12094-016-1569-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1043312651
    264 https://doi.org/10.1007/s12094-016-1569-y
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/bjc.2016.210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036915213
    267 https://doi.org/10.1038/bjc.2016.210
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/cr.2011.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017528148
    270 https://doi.org/10.1038/cr.2011.38
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1038/nrc1014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008818340
    273 https://doi.org/10.1038/nrc1014
    274 rdf:type schema:CreativeWork
    275 sg:pub.10.1038/nrclinonc.2011.95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022584996
    276 https://doi.org/10.1038/nrclinonc.2011.95
    277 rdf:type schema:CreativeWork
    278 sg:pub.10.1038/onc.2011.656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024757614
    279 https://doi.org/10.1038/onc.2011.656
    280 rdf:type schema:CreativeWork
    281 sg:pub.10.1038/pr.2013.217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037381848
    282 https://doi.org/10.1038/pr.2013.217
    283 rdf:type schema:CreativeWork
    284 sg:pub.10.1038/sj.bjc.6605014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053161948
    285 https://doi.org/10.1038/sj.bjc.6605014
    286 rdf:type schema:CreativeWork
    287 sg:pub.10.1038/sj.cr.7290134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025225165
    288 https://doi.org/10.1038/sj.cr.7290134
    289 rdf:type schema:CreativeWork
    290 sg:pub.10.1038/sj.onc.1205088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027779487
    291 https://doi.org/10.1038/sj.onc.1205088
    292 rdf:type schema:CreativeWork
    293 sg:pub.10.1038/srep46312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084812236
    294 https://doi.org/10.1038/srep46312
    295 rdf:type schema:CreativeWork
    296 sg:pub.10.1186/1746-1596-7-42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013484875
    297 https://doi.org/10.1186/1746-1596-7-42
    298 rdf:type schema:CreativeWork
    299 sg:pub.10.1186/s13045-015-0119-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026038001
    300 https://doi.org/10.1186/s13045-015-0119-3
    301 rdf:type schema:CreativeWork
    302 sg:pub.10.5625/lar.2011.27.2.147 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043688918
    303 https://doi.org/10.5625/lar.2011.27.2.147
    304 rdf:type schema:CreativeWork
    305 grid-institutes:None schema:alternateName CIBERONC, Madrid, Spain
    306 schema:name CIBERONC, Madrid, Spain
    307 Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ibáñez, 15, 46010 Valencia, Spain
    308 rdf:type schema:Organization
    309 grid-institutes:grid.5338.d schema:alternateName Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ibáñez, 15, 46010 Valencia, Spain
    310 schema:name Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ibáñez, 15, 46010 Valencia, Spain
    311 rdf:type schema:Organization
    312 grid-institutes:grid.84393.35 schema:alternateName Pediatric Oncology Unit, University and Polytechnic Hospital La Fe, Valencia, Spain
    313 schema:name Pediatric Oncology Unit, University and Polytechnic Hospital La Fe, Valencia, Spain
    314 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...